Contrasting Exponent (EXPO) & The Competition
Exponent (NASDAQ: EXPO) is one of 98 public companies in the “Business Support Services” industry, but how does it compare to its peers? We will compare Exponent to related companies based on the strength of its analyst recommendations, valuation, risk, institutional ownership, profitability, earnings and dividends.
Institutional & Insider Ownership
88.3% of Exponent shares are held by institutional investors. Comparatively, 62.9% of shares of all “Business Support Services” companies are held by institutional investors. 2.8% of Exponent shares are held by insiders. Comparatively, 12.1% of shares of all “Business Support Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Exponent pays an annual dividend of $0.84 per share and has a dividend yield of 1.1%. Exponent pays out 43.5% of its earnings in the form of a dividend. As a group, “Business Support Services” companies pay a dividend yield of 1.1% and pay out 26.9% of their earnings in the form of a dividend.
This table compares Exponent and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation and Earnings
This table compares Exponent and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Exponent||$311.50 million||$71.89 million||38.29|
|Exponent Competitors||$1.12 billion||$179.80 million||21.54|
Exponent’s peers have higher revenue and earnings than Exponent. Exponent is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
Exponent has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Exponent’s peers have a beta of 1.12, indicating that their average share price is 12% more volatile than the S&P 500.
This is a breakdown of recent ratings for Exponent and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Exponent currently has a consensus price target of $75.00, suggesting a potential upside of 1.49%. As a group, “Business Support Services” companies have a potential downside of 3.55%. Given Exponent’s stronger consensus rating and higher possible upside, equities analysts clearly believe Exponent is more favorable than its peers.
Exponent beats its peers on 9 of the 15 factors compared.
Exponent, Inc. (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences and vehicle analysis services. Its Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences, and health sciences. Exponent serves clients in automotive, government, health, insurance, manufacturing and technology, among others.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.